EC approves BMS’ Opdivo as adjuvant treatment for oesophageal or GEJ cancer patients

2nd August 2021 Uncategorised 0

The approval is based on Phase III results from the CheckMate-577 trial

More: EC approves BMS’ Opdivo as adjuvant treatment for oesophageal or GEJ cancer patients
Source: News